Dendritic cells hold promise for immunotherapy - PubMed (original) (raw)

Dendritic cells hold promise for immunotherapy

G Girolomoni et al. Immunol Today. 1997 Mar.

No abstract available

PubMed Disclaimer

Similar articles

• Exploiting dendritic cells for active immunotherapy of cancer and chronic infection.
  O'Neill D, Bhardwaj N. O'Neill D, et al. Methods Mol Med. 2005;109:1-18. Methods Mol Med. 2005. PMID: 15585909 Review.
• Dendritic cells, new tools for vaccination.
  Colino J, Snapper CM. Colino J, et al. Microbes Infect. 2003 Apr;5(4):311-9. doi: 10.1016/s1286-4579(03)00033-9. Microbes Infect. 2003. PMID: 12706444 Review.
• Biological properties of dendritic cells: implications to their use in the treatment of cancer.
  van Schooten WC, Strang G, Palathumpat V. van Schooten WC, et al. Mol Med Today. 1997 Jun;3(6):254-60. doi: 10.1016/S1357-4310(97)01047-2. Mol Med Today. 1997. PMID: 9211416 Review.
• Dendritic cells as natural adjuvants.
  Citterio S, Rescigno M, Foti M, Granucci F, Aggujaro D, Gasperi C, Matyszak MK, Girolomoni G, Ricciardi-Castagnoli P. Citterio S, et al. Methods. 1999 Sep;19(1):142-7. doi: 10.1006/meth.1999.0839. Methods. 1999. PMID: 10525450 Review.
• Dendritic cells as natural adjuvants and modulators of immune response in cancer immunotherapy.
  Alli RS, Khar A. Alli RS, et al. Indian J Biochem Biophys. 2002 Dec;39(6):363-7. Indian J Biochem Biophys. 2002. PMID: 22905392 Review.

Cited by

• Myeloid-derived suppressor cells in the patients with liver resection for hepatitis B virus-related hepatocellular carcinoma.
  Lee WC, Wang YC, Cheng CH, Wu TH, Lee CF, Wu TJ, Chou HS, Chan KM. Lee WC, et al. Sci Rep. 2019 Feb 19;9(1):2269. doi: 10.1038/s41598-019-38785-3. Sci Rep. 2019. PMID: 30783140 Free PMC article. Clinical Trial.
• HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment.
  Hartmann S, Bhola NE, Grandis JR. Hartmann S, et al. Clin Cancer Res. 2016 Aug 15;22(16):4005-13. doi: 10.1158/1078-0432.CCR-16-0951. Epub 2016 Jul 1. Clin Cancer Res. 2016. PMID: 27370607 Free PMC article. Review.
• Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity.
  Waugh KA, Leach SM, Slansky JE. Waugh KA, et al. Vaccines (Basel). 2015 Sep 17;3(3):771-802. doi: 10.3390/vaccines3030771. Vaccines (Basel). 2015. PMID: 26393659 Free PMC article. Review.
• Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.
  Hong S, Li H, Qian J, Yang J, Lu Y, Yi Q. Hong S, et al. Clin Exp Immunol. 2012 Nov;170(2):167-77. doi: 10.1111/j.1365-2249.2012.04642.x. Clin Exp Immunol. 2012. PMID: 23039887 Free PMC article.
• Human embryonic stem cell (hES) derived dendritic cells are functionally normal and are susceptible to HIV-1 infection.
  Bandi S, Akkina R. Bandi S, et al. AIDS Res Ther. 2008 Jan 23;5:1. doi: 10.1186/1742-6405-5-1. AIDS Res Ther. 2008. PMID: 18215326 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations